Corealis Pharma will be attending the MassBio Align Summit 2026 on October 15 at the Sheraton Boston Hotel.

MassBio’s annual partnering conference connects emerging life sciences companies with funders, industry leaders and strategic partners. This year’s summit will feature 55 early-stage companies, thought-leadership sessions and one-on-one partnering, with innovation spanning advanced biologics, AI-driven drug discovery and development, engineered molecular medicines, diagnostics and next-generation genetic technologies.

David Kwajewski will be representing Corealis Pharma and connecting with emerging biotech companies looking to move promising molecules from early development toward the clinic.

With expertise across pre-formulation, oral solid dose formulation development, analytical services, GMP clinical manufacturing, packaging and clinical supply, Corealis helps biotech companies build practical development strategies designed to keep programs moving efficiently.

Whether you’re evaluating formulation approaches, preparing for clinical manufacturing, or looking for an experienced CDMO partner as your program advances, connect with David in Boston.

Let’s talk about what’s next for your program.